Black Diamond Therapeutics, Inc. 10-Q filing
Filed 2025-08-07 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001701541-25-000030
- Form type
- 10-Q
- CIK
- 0001701541
- Primary document
- https://www.sec.gov/Archives/edgar/data/1701541/000170154125000030/bdtx-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Black Diamond Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $41.1M | - | - |
| Net Income | $46.0M | - | - |
| Eps Basic | 0.81 | - | - |
| Eps Diluted | 0.8 | - | - |
| Cash And Equivalents | $30.0M | - | - |
| Total Assets | $166.4M | - | - |
| Total Liabilities | $33.8M | - | - |
| Shareholders Equity | $132.6M | - | - |
| Operating Cash Flow | $44.3M | - | - |